Advocacy Service for Rare and Intractable Diseases’ multi-stakeholders in Japan


Issue AreaHealth

Tax benefit eligibilityUS

Share on Facebook Share on LinkedIn Share on Twitter Share to Instagram

Our Mission

ASrid is an intermediary organization that focuses on all rare and intractable diseases. We work with patients and other multi-stakeholders to generate evidence for policy and other recommendations, support drug development, and increase public awareness.

The Need

For patients with rare diseases and their families, we believe the following needs need to be identified: quality of life, policy advocacy, multi-stakeholder global collaboration, new diagnostic and treatment methods, employment support, and mental health care.

The Solution

Surveys and research for PRO utilization (qualitative and quantitative), Registry Management, Patient/patient association collaboration, Patient needs survey (R&D, social welfare), Workshop/portal site management, Social awareness campaign development, Global collaboration, Other.

Our Impact

ASrid has received several national and international academic awards for rare disease patient research. In addition, as an intermediary organization, ASrid actively collaborates with multi-stakeholders and, as the RDD Japan office, has successfully connected communities throughout Japan.

About this Organization

Issue AreaHealth

About Give2Asia

Give2Asia is a trusted partner for international philanthropy and the leader in donor-advised giving to the Asia-Pacific. Our mission is to strengthen communities in Asia by making cross-border giving easier and more effective. Since 2001, Give2Asia has facilitated more than US$465 million of charitable grants across 20+ countries.

Tax Benefit Eligibility

Gift acknowledgments and tax receipts can only be issued from the charitable entity to which you make your donation. Please ensure that you are giving to the Give2Asia entity in the location where you seek tax benefits (learn more). Donations cannot be refunded once an acknowledgment has been issued. If you have any questions, contact us before making your donation.

Select the charitable entity you wish to support:

Partner login